CHMP2B, linked genetically to frontotemporal dementia (FTD) and AD [23, 24], directly interacts with and recruits the VPS4 AAA–ATPase complex that disassembles ESCRT-III, and genome-wide association studies for late onset AD identified an association with VPS4B [25]. Here, VPS4A is linked to frontotemporal dementia.